new
viru
term
caus
diseas
exhibit
progress
fatal
impact
individu
world
health
organ
declar
spread
viru
global
pandem
current
million
case
confirm
death
due
viru
henc
prophylact
therapeut
strategi
promptli
need
studi
report
epitop
itlcftlkr
biochem
fit
hla
allel
protein
propos
could
use
potenti
vaccin
candid
select
put
epitop
hlaallel
complex
show
better
bind
score
also
rmsd
valu
rang
epitop
found
structur
favor
per
ramachandranplot
analysi
similarli
suitabl
rang
ic
valu
popul
coverag
obtain
repres
greater
valid
tcell
epitop
analysi
stabil
analysi
use
mdweb
halflif
analysi
use
protparam
tool
confirm
epitop
wellselect
new
methodolog
epitopebas
vaccin
predict
fundament
fast
applic
ad
econom
benefici
viabl
outbreak
hubei
region
chines
citi
wuhan
result
difficult
situat
global
populac
world
health
organ
jan
declar
emerg
regard
spread
prevent
control
march
case
confirm
death
affect
countri
present
updat
indic
million
confirm
case
death
worldwid
inform
obtain
http
wwwworldometersinfocoronaviru
coronaviru
rna
type
viru
posit
sens
strand
featur
associ
coronavirida
famili
order
nidoviral
found
dispers
among
primat
order
member
class
mammalia
specif
human
sever
acut
respiratori
syndrom
coronaviru
sarscov
middl
east
respiratori
disord
coronaviru
merscov
classifi
found
relat
novel
efficaci
therapi
regul
spread
investig
spread
across
contin
vulner
urgent
need
craft
vaccin
reinforc
immun
defens
viru
one
strategi
combat
develop
vaccin
initi
adapt
immun
respons
human
attempt
made
design
epitop
base
vaccin
direct
analyz
proteom
viru
use
immunoinformat
tool
studi
deploy
use
variou
bioinformat
server
immunoinformat
tool
identifi
recogn
tcell
epitop
intens
studi
avail
protein
sequenc
structur
relat
epitop
stretch
interact
mhc
class
class
ii
hla
allel
valid
epitop
analyz
ramachandran
plot
analysi
antigen
paramet
evalu
toxic
analysi
popul
coverag
molecular
dynam
protparam
analysi
approach
excel
method
modern
vaccin
design
provid
lead
classic
trial
error
method
wet
lab
tri
identifi
tcell
epitop
elicit
robust
immun
respons
global
human
popul
act
potenti
vaccin
candid
howev
abil
epitop
act
vaccin
candid
need
analyz
molecular
biolog
lab
studi
investig
open
new
dimens
craft
peptidebas
vaccin
regimen
novel
greatest
declin
viru
expans
note
follow
remov
encod
type
transmembran
protein
structur
studi
disclos
pack
sevenstrand
sandwich
compar
fold
topolog
member
immunoglobulin
super
famili
sarscov
envelop
positivestrand
rna
viru
genom
around
base
genom
incorpor
least
open
read
frame
orf
encod
protein
three
distinct
class
two
larg
polyprotein
cleav
nonstructur
protein
viral
rna
synthesi
four
structur
protein
e
n
necessari
viral
entranc
gather
eight
accessori
protein
assum
dispens
viral
replic
may
facilit
viral
assembl
take
part
virul
pathogenesi
figur
investigatori
studi
five
two
protein
name
specif
found
put
tcell
epitop
determin
creat
use
inform
distinguish
protein
also
import
viral
replic
growth
protein
may
influenc
viral
pathogenesi
diseas
spread
although
literatur
lack
unanim
bcell
epitop
predict
still
consid
untrustworthi
linear
conform
epitop
compar
tcell
epitop
furthermor
bcell
epitop
elicit
strong
antibodi
respons
reason
tcell
epitop
consid
present
studi
capabl
produc
tcell
longlast
respons
one
recent
studi
epitop
design
focus
singl
protein
ie
spike
protein
gener
multipl
epitop
like
mhc
mhc
ii
analyz
multipl
protein
screen
effect
epitop
base
variou
insilico
filter
provid
appropri
authent
epitop
test
wet
lab
five
protein
sequenc
select
ncbigenbank
list
tabl
base
allergen
reli
tanimoto
similar
index
score
produc
epitop
structur
find
conduct
use
server
mhc
hla
allel
peptid
tertiari
structur
obtain
rcsbpdb
databas
select
epitop
hla
complex
dock
calcul
refin
interact
bind
energi
along
atom
contact
energi
ace
use
two
dock
webserv
patchdock
molecular
dynam
studi
conduct
analyz
rmsd
valu
atom
fluctuat
amino
acid
ps
time
frame
deploy
mdweb
server
mdweb
server
deploy
analyz
coars
grain
md
brownian
dynam
calpha
specif
time
ps
output
frequenc
step
forc
constant
kcalmol
distanc
alpha
carbon
atom
interact
epitop
base
gromac
md
setup
solvat
use
forcefield
toxinpr
server
util
determin
toxic
score
epitop
select
nontox
one
also
ramachandran
plot
analysi
deploy
use
nonallergen
protein
select
base
allergen
score
deploy
allergenfp
new
netmhcii
pan
netmhc
server
determin
valu
affin
valu
select
best
possibl
pair
epitop
correspond
hla
allel
tabl
tabl
result
mhc
class
hla
mhc
class
ii
hla
allel
epitop
structur
obtain
use
webserv
hla
allel
structur
retriev
rcsbpdb
databas
tabl
crystal
structuremodel
structur
detail
refer
pdbid
provid
figur
interact
select
three
tcell
epitop
respect
mhc
class
ii
hlaallel
via
hydrogen
bond
format
van
der
waal
interact
depict
posit
dock
result
epitop
subject
molecular
dynam
simul
biochem
paramet
assess
figur
repres
graphic
plot
bind
score
epitop
interact
hlaallel
toxinpr
server
result
tabl
repres
final
tcell
epitop
nontox
biochem
perspect
figur
suggest
residu
allow
favor
region
give
confid
structur
conform
target
tcell
epitop
mhcpred
result
surmis
screen
effect
use
primarili
molecular
dock
reveal
three
epitop
proceed
molecular
dynam
simul
reveal
best
interact
two
epitop
ie
itlcftlkr
vyqlrarsv
accept
stabil
analyz
help
mdweb
identifi
use
best
avail
tool
easytoappli
method
one
recent
studi
found
focus
develop
monoclon
antibodi
like
spike
protein
also
exhibit
interact
ace
satisfactori
popul
coverag
observ
target
epitop
hla
allel
complex
worldwid
south
asia
india
level
biochem
integr
epitop
structur
evid
deploy
ramachandran
plot
analysi
epitop
nontox
nonallergen
possess
good
antigen
similar
studi
preliminari
analysi
vaccin
target
investig
tri
use
spike
protein
nucleocapsid
protein
sequenc
sarscov
homolog
extant
protein
determin
multipl
differ
epitop
vaccin
predict
studi
five
two
protein
name
specif
found
put
tcell
epitop
determin
creat
use
inform
protein
also
import
viral
replic
biochem
paramet
well
advanc
hmm
ann
base
algorithm
select
immunoinformat
tool
use
present
clear
pictur
predict
epitop
craft
vaccin
limit
consid
futur
scope
easili
synthes
peptid
test
invitro
studi
practic
valid
itlcftlkr
epitop
select
craft
design
vaccin
particular
epitop
good
antigen
exhibit
activ
bind
mhc
hlaallel
maximum
popul
coverag
differ
geograph
region
therefor
peptid
use
vaccin
design
wet
lab
verif
novel
approach
also
assist
life
scienc
research
group
reduc
time
monetari
expenditur
well
physic
hittrial
effort
